Evox Therapeutics was established in 2016 to advance leading edge science from Oxford University and the Karolinska Institute. We work to develop innovative exosome therapeutics for diseases with significant unmet medical need.
Backed by leading venture capital groups and leveraging a comprehensive dominant intellectual property portfolio Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of rare and severe diseases with limited treatment options for patients and their families.
We have already recruited exceptional people working in multidisciplinary teams, sharing our mission to transform how we treat rare diseases. Why not join our team and make your contribution to our journey ahead.
Workplace & Culture
At Evox, values are at the heart of how we operate, how we behave, and how we will drive the growth of our exciting company.
We developed the values internally with all our employees, ones which we could all identify and work with.
strive for excellence
Private Medical Cover
Cover offered is for new and pre-existing conditions
Cover offered is 4 x base salary
25 days holiday plus bank holidays
Employer contribution 5%, employee minimum contribution 5%, however, more than 5% can be contributed if you wish
Bonus is payable based on a combination of corporate and personal performance
We operate a closed preferred supplier list that doesn’t allow agencies to register with us or send CVs to us. This is made up from carefully selected specialist scientific agencies, and we are not looking to add to our suppliers. Please do not call or email if you are a recruitment agency.